Novel heterocyclic compounds, which exhibit a dopamine receptor (preferably a D4 receptor) agonistic activity, and/or a PDE5 inhibitory activity, processes of preparing same, pharmaceutical compositions containing same and uses thereof in the treatment of sexual disorders such as decreased libido, orgasm disorder and erectile dysfunction are disclosed.
本发明揭示了一种新型
杂环化合物,其表现出
多巴胺受体(优选为
D4受体)激动活性和/或PDE5抑制活性,以及制备该化合物的方法,含有该化合物的药物组合物以及将其用于治疗性功能障碍,如性欲减退、性高潮障碍和勃起功能障碍的用途。